Clinical Trial Update: A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing sunitinib plus capecitabine versus capecitabine alone in breast cancer has completed, with results posted in January 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Sunitinib (sunitinib)

Snippet

Sponsor: Pfizer | Conditions: Breast Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2011-01-13